Ronald Pharmaceuticals Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 26-06-2024
- Paid Up Capital ₹ 0.85 Cr
as on 26-06-2024
- Company Age 31 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.63 Cr
as on 26-06-2024
- Satisfied Charges ₹ 21.00 Cr
as on 26-06-2024
- Revenue 55.85%
(FY 2022)
- Profit 38.76%
(FY 2022)
- Ebitda -51.54%
(FY 2022)
- Net Worth 26.20%
(FY 2022)
- Total Assets 6.92%
(FY 2022)
About Ronald Pharmaceuticals
The Corporate was formerly known as Dupont Organics Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.85 Cr.
The company currently has active open charges totaling ₹14.63 Cr. The company has closed loans amounting to ₹21.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vedant Maheshwari and Nandkishore Maheshwari serve as directors at the Company.
- CIN/LLPIN
U24110GJ1993PTC019347
- Company No.
019347
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ronald Pharmaceuticals?
Board Members(2)
Financial Performance and Corporate Structure Insights of Ronald Pharmaceuticals.
Ronald Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 55.85% increase. The company also saw a substantial improvement in profitability, with a 38.76% increase in profit. The company's net worth Soared by an impressive increase of 26.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ronald Pharmaceuticals?
Unlock access to Ronald Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Savorite Pharmaceuticals Private Limited
Active
5 years 8 months Vedant Maheshwari and Nandkishore Maheshwari are mutual person
Mypher Pharmaceuticals Llp
Active 9 years 11 months Vedant Maheshwari and Nandkishore Maheshwari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Mar 2023 | ₹1.01 M | Open |
Others Creation Date: 29 Jun 2020 | ₹4.96 Cr | Open |
Others Creation Date: 07 Dec 2019 | ₹4.96 Cr | Open |
How Many Employees Work at Ronald Pharmaceuticals?
Unlock and access historical data on people associated with Ronald Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ronald Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ronald Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
